Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 200
- 试验地点
- 2
- 主要终点
- Recovery respiratory fail
研究概览
简要总结
Vibroacoustic pulmonary therapy in patients with COVID19 is believed to have a positive effect on oxygen status and a decrease in the duration of respiratory failure
详细描述
This study aims to recruit the required number of patients for statistical identification of the effectiveness of vibroacoustic therapy in patients with COVID 19. Obligatory performance criteria will be presented by the duration of the course of respiratory failure and the duration of mechanical ventilation in the main and control groups. Optional performance criteria will be represented by oximetry values and standardization of laboratory parameters
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
盲法说明
Research involves single blinding (researcher statistician)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •P/F less 300 torr
- •ARDS by Berlin convention
- •COVID 19 bilateral pneumonia
排除标准
- •acute brain stroke
- •acute coronary syndrome
- •pulmonary embolism
- •implanted pacemaker
研究组 & 干预措施
Time-day of respiratory fail
Objective data
干预措施: VibroLUNG (Device)
Oxygen status
Facultative data
干预措施: VibroLUNG (Device)
Oxugen support
FiO2
干预措施: VibroLUNG (Device)
Adverse outcomes
Complication
干预措施: VibroLUNG (Device)
结局指标
主要结局
Recovery respiratory fail
时间窗: 5-7 days
Regression of respiratory failure under the influence of vibroacoustic therapy
次要结局
未报告次要终点
研究者
Mukatova Irina
PhD. Professor of medicine. Head of deparment pulmonology
Astana Medical University